RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 16.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $380,000 | -23.4% | 104,662 | -8.4% | 0.17% | -18.1% |
| Q2 2021 | $496,000 | +57.5% | 114,256 | +24.2% | 0.20% | +53.4% |
| Q1 2021 | $315,000 | -0.3% | 91,971 | +1.8% | 0.13% | +1.5% |
| Q4 2020 | $316,000 | -23.1% | 90,356 | -47.2% | 0.13% | -39.4% |
| Q3 2020 | $411,000 | +15.4% | 171,235 | -12.0% | 0.22% | +27.8% |
| Q2 2020 | $356,000 | +41.3% | 194,583 | +20.7% | 0.17% | +62.5% |
| Q1 2020 | $252,000 | -36.2% | 161,235 | -12.7% | 0.10% | +60.0% |
| Q4 2019 | $395,000 | -47.4% | 184,740 | -21.1% | 0.06% | -16.7% |
| Q3 2018 | $751,000 | +21.7% | 234,017 | +7.4% | 0.08% | -85.7% |
| Q2 2018 | $617,000 | -18.2% | 217,985 | +2.4% | 0.54% | -16.7% |
| Q1 2018 | $754,000 | +96.9% | 212,882 | +115.6% | 0.65% | +36.0% |
| Q4 2017 | $383,000 | +19.3% | 98,726 | -21.9% | 0.48% | +1018.6% |
| Q3 2017 | $321,000 | +2.6% | 126,385 | +10.1% | 0.04% | -8.5% |
| Q2 2017 | $313,000 | -15.9% | 114,825 | +2.2% | 0.05% | -28.8% |
| Q1 2017 | $372,000 | +53.7% | 112,403 | +10.6% | 0.07% | -8.3% |
| Q4 2016 | $242,000 | – | 101,628 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |